Literature DB >> 2908608

Aromatase inhibitors as new endocrine therapy for breast cancer.

A M Brodie, M Dowsett, R C Coombes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2908608     DOI： 10.1007/978-1-4613-1731-9_4

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  3 in total

Review 1.  Endocrine therapy for advanced breast cancer: a review.

Authors:  H B Muss
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Real-World Experience with CDK4/6 Inhibitors for Metastatic HR+/HER2- Breast Cancer at a Single Cancer Center.

Authors:  Erik S Knudsen; Emily Schultz; Deanna Hamilton; Kris Attwood; Stephen Edge; Tracey O'Connor; Ellis Levine; Agnieszka K Witkiewicz
Journal:  Oncologist       Date:  2022-08-05       Impact factor: 5.837

Review 3.  Insights into Orphan Nuclear Receptors as Prognostic Markers and Novel Therapeutic Targets for Breast Cancer.

Authors:  Reidun Aesoy; Colin D Clyne; Ashwini L Chand
Journal:  Front Endocrinol (Lausanne)       Date:  2015-08-07       Impact factor: 5.555
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.